国药集团致君（深圳）制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
103
NMPA:103
Drug Approvals
Oseltamivir Phosphate for Suspension
- Product Name
- 磷酸奥司他韦干混悬剂
- Approval Number
- 国药准字H20253530
- Approval Date
- Mar 4, 2025
NMPA
Cefprozil for Suspension
- Product Name
- 头孢丙烯干混悬剂
- Approval Number
- 国药准字H20253211
- Approval Date
- Jan 14, 2025
NMPA
Cefpodoxime Proxetil Tablets
- Product Name
- 头孢泊肟酯片
- Approval Number
- 国药准字H20249692
- Approval Date
- Dec 6, 2024
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20243069
- Approval Date
- Jan 23, 2024
NMPA
Clopidogrel Bisulfate Tablets
- Product Name
- 硫酸氢氯吡格雷片
- Approval Number
- 国药准字H20234612
- Approval Date
- Dec 5, 2023
NMPA
Desloratadine Oral Solution
- Product Name
- 地氯雷他定口服溶液
- Approval Number
- 国药准字H20233918
- Approval Date
- Jul 11, 2023
NMPA
Cefathiamidine for Injection
- Product Name
- 注射用头孢硫脒
- Approval Number
- 国药准字H20143010
- Approval Date
- Jun 14, 2023
NMPA
Cefathiamidine for Injection
- Product Name
- 注射用头孢硫脒
- Approval Number
- 国药准字H20143012
- Approval Date
- Jun 14, 2023
NMPA
Cefathiamidine for Injection
- Product Name
- 注射用头孢硫脒
- Approval Number
- 国药准字H20143011
- Approval Date
- Jun 14, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
Clinical Trials
No trials found
News
No news found